Gaia Moretta (G Moretta)

Publication Activity (10 Years)

Years Active: 2021-2022
Publications (10 Years): 7

Top Topics

Infectious Diseases

Ejection Fraction

Atopic Dermatitis

Top Venues

Dermatologic therapy

Expert opinion on biological therapy

International journal of molecular sciences

This page only lists publications with an associated author ORCID identifier.

Publications

Giacomo Caldarola, Marco Galluzzo, Nicoletta Bernardini, Laura Calabrese, Marta Grimaldi, Gaia Moretta, Gianluca Pagnanelli, Ruslana Gaeta Shumak, Marina Talamonti, Lorenzo Tofani, Sabatino Pallotta, Ketty Peris, Concetta Potenza, Clara De Simone, Elena Campione
Tildrakizumab in moderate-to-severe plaque psoriasis: A multicenter, retrospective, real-life study. Dermatologic therapy 35 (6) (2022)
Giacomo Caldarola, Arianna Zangrilli, Nicoletta Bernardini, Mauro Bavetta, Clara De Simone, Dario Graceffa, Claudio Bonifati, Sara Faleri, Domenico Giordano, Marco Mariani, Adriana Micheli, Gaia Moretta, Gianluca Pagnanelli, Vincenzo Panasiti, Alessia Provini, Antonio Richetta, Ketty Peris, Luca Bianchi
Risankizumab for the treatment of moderate-to-severe psoriasis: A multicenter, retrospective, 1 year real-life study. Dermatologic therapy 35 (6) (2022)
Luca Fania, Gaia Moretta, Flaminia Antonelli, Enrico Scala, Damiano Abeni, Cristina Albanesi, Stefania Madonna
Multiple Roles for Cytokines in Atopic Dermatitis: From Pathogenic Mediators to Endotype-Specific Biomarkers to Therapeutic Targets. International journal of molecular sciences 23 (5) (2022)
Marco Galluzzo, Marina Talamonti, Nicoletta Bernardini, Andrea Chiricozzi, Clara De Simone, Claudio Bonifati, Pierluigi Bruni, Diotallevi Federico, Maria Esposito, Dario Graceffa, Katharina Hansel, Francesco Loconsole, Gaia Moretta, Cristina Mugheddu, Manuela Papini, Antonio Giovanni Richetta, Nevena Skroza, Laura Atzori, Maria-Concetta Fargnoli, Severino Persechino, Annamaria Offidani, Luca Stingeni, Ketty Peris, Concetta Potenza, Luca Bianchi
Real-world outcomes in patients with moderate-to-severe plaque psoriasis treated with guselkumab for up to 1 year. Expert opinion on biological therapy (2022)
Marco Galluzzo, Giacomo Caldarola, C De Simone, N Bernardini, Gaia Moretta, Sabatino Pallotta, E Botti, Elena Campione, Federico Pirro, C Potenza, Luca Bianchi, Ketty Peris
Use of brodalumab for the treatment of chronic plaque psoriasis: a one-year real-life study in the Lazio region, Italy. Expert opinion on biological therapy 21 (9) (2021)
Arianna Zangrilli, Giacomo Caldarola, Nicoletta Bernardini, Mauro Bavetta, Dario Graceffa, Claudio Bonifati, Franca Cantoresi, Sara Faleri, Domenico Giordano, Marco Mariani, Adriana Micheli, Gaia Moretta, Federico Pirro, Gianluca Pagnanelli, Vincenzo Panasiti, Alessia Provini, Antonio Giovanni Richetta, Lidia Sacchelli, Luca Bianchi, Ketty Peris
Predictive factors of lack of response to adalimumab among bio-naive patients suffering from moderate-to severe psoriasis: analysis of a multicenter data collection in Italy. Expert opinion on biological therapy 21 (9) (2021)
Luca Fania, Elena Dellambra, Gaia Moretta, Elisabetta Grilli, Christiana Zorika Di Rocco, Francesca Maria Morelli, Albina Rita Zappalà, Damiano Abeni, Roberto Morese
Efficacy of sonidegib for basal cell carcinoma in a patient affected by multiple infectious diseases. Dermatologic therapy 34 (4) (2021)